Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.
Press releases published on April 28, 2025
ReversingLabs Named Winner of the Global InfoSec Awards at RSA 2025 Conference
GlobeNewswire
·
April 28, 2025
ReversingLabs Spectra Assure® Named Most Advanced Software Supply Chain Security Solution SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- RSAC 2025: Booth N-4428 — ReversingLabs (RL), the trusted name in file and software security, today announced that …
Nexamp Closes $340 Million of Institutional Debt Facilities with PGIM Private Capital
GlobeNewswire
·
April 28, 2025
Boston, April 28, 2025 (GLOBE NEWSWIRE) -- Nexamp, a leading national developer and operator of distributed solar and energy storage systems, has successfully closed a $340 million private placement debt refinancing with PGIM Private Capital (PPC), the …
CPS Technologies Corp. Conference Call Notification
GlobeNewswire
·
April 28, 2025
NORTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- CPS Technologies Corp. (Nasdaq:CPSH) today released instructions for its first quarter 2025 investor conference call which will be held on Thursday May 1, 2025 at 9:00 A.M. (Eastern). Brian Mackey, …
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
GlobeNewswire
·
April 28, 2025
Company is advancing portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Lead candidate JADE-001 on track to enter the clinic in second half of 2025, with initial data expected in first half of 2026 …
MKS Instruments to Participate in JP Morgan’s 53rd Annual Global Technology, Media and Communications Conference
GlobeNewswire
·
April 28, 2025
ANDOVER, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced today that John T.C. Lee, President and Chief Executive Officer, will participate in a …
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
GlobeNewswire
·
April 28, 2025
JERUSALEM, April 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that it has successfully closed a …
Lumina Datamatics Honored with IMC RBNQ Certificate of Merit and Milestone Merits Recognitions for 2024
GlobeNewswire
·
April 28, 2025
MUMBAI, India, April 28, 2025 (GLOBE NEWSWIRE) -- Lumina Datamatics, a global leader in content, retail support, and technology solutions, has been recognized with the IMC Ramkrishna Bajaj National Quality (RBNQ) Awards for 2024 in the following categories …
Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 28, 2025
CTX-471 monotherapy demonstrated efficacy in multiple murine models, including models highly resistant to immune checkpoint inhibitors. Combining CTX-471 with tovecimig (CTX-009) markedly increased anti-tumor efficacy in these models. Tovecimig in …
Crescent Biopharma Appoints David Lubner to Board of Directors
GlobeNewswire
·
April 28, 2025
Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent”), a private biotechnology company developing novel precision-engineered molecules …
ElevateBio Announces Transition of David Hallal to Executive Chairman of the Board of Directors
GlobeNewswire
·
April 28, 2025
WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, announced that David Hallal will transition from Chairman and CEO to Executive Chairman of …
BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
GlobeNewswire
·
April 28, 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that President and CEO Niven R. Narain, Ph.D. has been named to The Medicine Maker’s Power List 2025. The annual list …
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
GlobeNewswire
·
April 28, 2025
WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today …
Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-positive/HER2-negative Breast Cancer
GlobeNewswire
·
April 28, 2025
CDK2 molecular glue degrader (MGD) in combination with CDK4/6 inhibition and anti-estrogen therapy achieved superior tumor regression in vivo compared to standard of care CDK4/6 inhibition and anti-estrogen therapy CDK2 MGD delayed resistance to CDK4/6 …
AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer
GlobeNewswire
·
April 28, 2025
MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announced the appointment of Mr …
Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate …
Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025
GlobeNewswire
·
April 28, 2025
Lead development candidate, AMP-410, leverages proprietary Ampersand technology to block VEGF and allosterically activate 4-1BB signaling – unlike traditional bispecific molecules – driving both adaptive and innate anti-tumor activity In multiple …
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
GlobeNewswire
·
April 28, 2025
BEDFORD, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it plans to issue a press release regarding first quarter …
Tyton Partners Releases New Report on Affordable Access Programs for Course Materials
GlobeNewswire
·
April 28, 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Tyton Partners today released a new report, Course Materials in Higher Education: How Affordable Access Programs Save Students Money and Produce Positive Learning Outcomes. The publication, which presents data …